We’re on a mission to educate people on the importance of checking their blood pressure regularly. Why? Because raised BP is the number one cause of preventable death worldwide.

May Measurement Month is a global blood pressure screening awareness campaign, launched in 2017 by our founding partner, the International Society of Hypertension.

Our aim is to highlight the importance of measuring your blood pressure (BP) and to raise awareness of the dangers posed by elevated BP and hypertension. Our target is to increase the numbers of participants aged 18+ who are regularly getting their BP checked and to give people the tools to understand how this information can contribute to your knowledge about your individual health. MMM also provides diet and lifestyle advice to those with BP in the hypertensive range and to facilitate improved follow up for sufferers.

On a broader level, MMM uses the data on inadequately treated hypertension to motivate governments to improve BP screening facilities and reduce the huge global burden of disease and death caused by raised BP.

Since 2017, volunteers in more than 100 countries have screened people in cities, towns, and rural villages as part of the largest FREE public blood pressure screening programme in the world. All participants discovered their blood pressure, and anyone who registered as hypertensive was given advice about what they need to do next.

May Measurement Month will take place between 01 May – 31 August 2022 and builds on the WHL’s established World Hypertension Day (held on 17 May each year) with volunteer health professionals at local screening sites, in more than 85 countries.

Professor Neil Poulter, Former ISH President (2016 -2018), and Chief Investigator of MMM, stated:

“Even with increased threats to public health this last year, raised blood pressure remains the biggest single contributing risk factor for global death and the worldwide burden of disease. We want May Measurement Month to increase public understanding, and help save lives that need not be lost ”

MMM Trustees

Professor Neil Poulter FMedSci

Professor of Preventive Cardiovascular Medicine, Imperial College London, London, United Kingdom

Neil qualified at St Mary’s Hospital in 1974, following which, he trained in General medicine. He spent five years in Kenya co-ordinating a collaborative hypertension research programme at the Wellcome Trust Research Laboratories in Nairobi. In 1985 he gained an MSc in Epidemiology with distinction at the London School of Hygiene and Tropical Medicine. In 1997 he was appointed Professor of Preventive Cardiovascular Medicine at Imperial College London. In 2008, Neil was elected as one of the inaugural Senior Investigators of the NIHR and as a fellow of the Academy of Medical Sciences the following year, in 2009. He held the position of President of the British Hypertension Society from 2003-2005 and also President of the International Society of Hypertension from 2016-2018.

An Honorary Consultant Physician and Epidemiologist at the Peart-Rose (CVD Prevention) Clinic based at Hammersmith Hospital, London, Neil is also Co-Pl of the WHO Oral Contraceptive case-control Study at University College London Medical School. He is currently co-Director of the International Centre for Circulatory Health and Director of the Imperial Clinical Trials Unit and has also held a senior management role in several international trials including the ASCOT, ADVANCE, EXSCEL, DEVOTE LEADER and CREOLE trials. Neil has published over 650 papers in peer-reviewed medical journals, including co-authoring several sets of national and international guidelines and has been identified as being among the top 1% most cited academics in clinical medicine in 2014 (Thomson Reuters Highly Cited Researcher report) and among the top 0.1% most cited researcher between 2008-2018 (Web of Science Group Highly Cited Researcher 2019 and 2020 report). Neil is the Chief Investigator of the May Measurement Month.

Professor Markus Schlaich

President, High Blood Pressure Research Council of Australia

Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist. He is an International Society of Hypertension (ISH) Fellow and has been on the Executive Committee of the ISH from 2018-2020 acting  as Treasurer and Chair of the Asia-Pacific Regional Advisory Group. He currently serves on the Management Board of the global ISH May Measurement Month campaign. Markus is President of the High Blood Pressure Research Council of Australia and a Trustee of the Foundation for High Blood Pressure Research.

Markus has a strong background in clinical research with a focus on the pathophysiology of hypertension, involvement of the kidneys, and hypertension mediated organ damage. He has a specific interest in treatment modalities targeting the sympathetic nervous system and is a founding member of the ESH Working Group on Interventional Treatment of Hypertension. For his work he received the Björn Folkow Award from the ESH and the Arthur C. Corcoran Award from the AHA Hypertension Council, both in 2021. He has authored more than 400 articles and book chapters in peer reviewed journals and serves on the Editorial Board of Hypertension and Journal of Hypertension.

Professor George S. Stergiou, MD, FRCP

Professor of Medicine & Hypertension
Hypertension Center STRIDE-7 (EU), Third University Dept. of Medicine, Sotiria Hospital, Athens.

George is the Chairman of the European Society of Hypertension (ESH) Working Group on blood pressure (BP) Monitoring & Cardiovascular Variability as well as the Chairman of STRIDE BP International Organization on BP measurement methodology and technology www.stridebp.org. He is the World Hypertension League Special Envoy for BP Measurement and an ISO Committee Member on BP monitoring equipment. George is also an Executive Committee member of the International Pediatric Hypertension Association. His research work has focused on BP monitoring methodology, technology development and validation; Hypertension diagnostics; Hypertension epidemiology, control; Pediatric hypertension; Antihypertensive drug action. George has authored 350 PubMed articles and supervised 25 MD theses (h-index 74;Google Scholar citations 45,000). George is also an International Society Hypertension (ISH) Council member.

Professor Alta Schutte PhD FRSSAf FESC ISHF

Professor of Cardiovascular Medicine, University of New South Wales, Australia

Alta Schutte is Professor of Cardiovascular Medicine and Principal Lead of the Cardiac, Vascular and Metabolic Medicine Theme at the University of New South Wales, and the George Institute for Global Health in Sydney, Australia. She is also Honorary Professor at the University of the Witwatersrand and North-West University, South Africa.

She has >400 publications in the field of hypertension and cardiovascular disease, focusing on clinical epidemiological and population-based work on the development and management of raised blood pressure. She is an invited author of the Lancet Commission of Hypertension and senior author of the 2020 ISH Global Hypertension Practice Guidelines. She is the Immediate Past President of the International Society of Hypertension.

If you want to find out more contact us here

Or if you want to find out more contact us here

Email: info@maymeasure.org